acute mastitis
Conditions
Interventions
Control group:cefdinir administered orally three times a day, along with SGSY placebo taken twice a day.
Experimental group:SGSY granule administered orally twice a day, along with cefdinir placebo taken three times a day
Sponsors
The third Hospital affiliated to Beijing University of Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: (1) Meets diagnostic criteria for lactational mastitis. (Guidelines for the diagnosis and management of chronic obstructive pulmonary disease (revised 2021 version) (2) Course = 72 hours no abscess detected on ultrasonography. (3)=4 point according to Visual Analogue Seal (VAS) (4) Fever higher than 37.2? PT(Peak Temperature) 12×109/L (6) Voluntary written informed consent obtained.
Exclusion criteria
Exclusion criteria: (1) Excludes other breast or metabolic disorders that contraindicate breastfeeding. (2) Treated with pharmacotherapy for the current episode of acute suppurative mastitis. (3) History of cephalosporin allergy and antibiotic abuse. (4) Patients with severe heart liver or kidney diseases (laboratory values exceeding the normal range by more than twofold). (5) Patients with comorbid psychiatric disorders epilepsy cognitive impairments or other major illnesses. (6) Patients with other infectious diseases undergoing treatment with traditional Chinese medicine or antibiotics. (7) Pregnant during lactation. (8) Participating in other clinical studies. (9) Patients considered by the investigator to be unsuitable for participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| body temperature;Dyspepsia VAS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Breast mass area;TCM patterns;Laboratory tests;Engorgement and Skin Erythema Score;Recurrence rate;Recovery rate; | — |
Countries
China
Contacts
Public ContactYingyi Fan
The third Hospital affiliated to Beijing University of Chinese Medicine
Outcome results
None listed